Understanding Neurologic Complications Following TAVR

Area of Science:

• Cardiology
• Neurology
• Medical Device Technology

Background:

• Transcatheter aortic valve replacement (TAVR) is a primary treatment for severe, symptomatic aortic stenosis.
• TAVR indications have expanded to intermediate-risk patients.
• Peri-procedural stroke remains a significant risk, with higher incidence than previously understood.

Purpose of the Study:

• To review stroke definitions and recommendations from academic research consortiums.
• To analyze stroke rates reported in transcatheter aortic valve replacement device trials.
• To highlight the need for precise trial endpoints for evaluating neuroprotective devices in TAVR.

Main Methods:

• Literature review of academic research consortium recommendations.
• Analysis of stroke definitions and reported incidence rates from TAVR clinical trials.
• Synthesis of findings to assess current methodologies for stroke assessment.

Main Results:

• Existing stroke definitions and endpoints vary across studies.
• Reported peri-procedural stroke rates in TAVR are higher than initially estimated.
• There is a critical need for standardized, meaningful endpoints for neuroprotection evaluation.

Conclusions:

• Standardized stroke definitions are crucial for accurate TAVR outcome assessment.
• Improved endpoints are necessary for evaluating the efficacy of neuroprotective strategies during TAVR.
• Further research should focus on refining outcome measures to better understand and mitigate TAVR-related stroke risk.